University of Washington researchers developed engineered protein switches that precisely control therapeutic protein activity duration in the body. Unlike traditional affinity modulation, these switches regulate binding lifetimes, enabling dynamic control over drug action to enhance safety and efficacy. Published in Nature, this approach paves the way for smarter biologics that adapt in real time to physiological conditions, potentially revolutionizing precision medicine and reducing off-target effects.